Microencapsulation of recombinant adenovirus within poly-DL-lactide-poly(ethylene glycol) microspheres for enhanced gene transfection efficiency and inhibitory effects on hepatocellular carcinoma cells in vitro

Xia,Dong; Feng,Li-Bo; Wu,Xiao-Long; Xia,Guo-Dong; Xu,Liang

doi:10.3892/mmr.2015.3578

Microencapsulation of recombinant adenovirus within poly-DL-lactide-poly(ethylene glycol) microspheres for enhanced gene transfection efficiency and inhibitory effects on hepatocellular carcinoma cells in vitro

Authors:
- Dong Xia
- Li-Bo Feng
- Xiao-Long Wu
- Guo-Dong Xia
- Liang Xu
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan 646000, P.R. China, Department of Gastroenterology, Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan 646000, P.R. China
Published online on: April 1, 2015 https://doi.org/10.3892/mmr.2015.3578
Pages: 2336-2342

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

When gene therapy is performed for the treatment of malignant tumors, gene transfer efficiency and selectivity are highly important. Polymer vehicle microspheres are a novel type of therapy, which have been developed rapidly in recent years and are able to control drug release, prolong the biological half‑life of drugs, decrease side effects and achieve targeted delivery. The present study was designed to construct a polymer microsphere-encapsulated recombinant adenovirus with human tissue inhibitors of the matrix metalloproteinase‑1 (TIMP‑1) gene, and to discuss its characterization for the purpose of liver cancer gene therapy. The microsphere was prepared from biodegradable poly‑DL‑lactide‑poly(ethylene glycol) (PELA) encapsulating rAdTIMP‑1, the recombinant adenovirus carrying TIMP‑1, by a modiﬁed double‑emulsion method. The particle morphology, diameter, virus encapsulation, loading rate and release kinetics of the rAd‑microspheres were determined in vitro. Hepatocellular carcinoma (HCC) HepG2 cells were transfected with the rAd‑microsphere and the efficiency of transfection was assessed by fluorescent microscopy. The production and expression of TIMP‑1 was identified by gelatin zymography and western blot analysis, and the invasiveness was detected by a matrigel matrix invasion assay. The microsphere encapsulating rAdTIMP‑1 was successfully constructed with a diameter of 1.965 µm, encapsulation efficiency of 60.0%, a viral load of 10.5x108/mg, a virus release of ~60% within 120 h and a total release time of >240 h. The resultant rAd‑microspheres were able to efficiently transfect HepG2 cells with the transfection efficiency enhanced by ~90%. As a result, the transfected HepG2 cells had significantly increased TIMP‑1 enzyme activity and the expression of TIMP‑1 was detected by western blot analysis. In addition, the proliferation and invasion ability of the HCC cells was markedly inhibited by the rAd‑microspheres. The resultant rAd‑microspheres, PELA-encapsulated recombinant TIMP‑1 adenovirus, had enhanced transfection efficiency and were able to markedly inhibit the in vitro biological behavior of HepG2 cells. This provides an experimental basis for this polymer application and may pave the way for prospective in vivo clinical trials and further comprehensive therapy for liver cancer.

View Figures

View References

1	Hernandez-Gea V, Toffanin S, Friedman SL and Llovet JM: Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
2	Chen JS, Huang XH, Wang Q, et al: Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis. 34:10–19. 2013. View Article : Google Scholar
3	Giri TK, Choudhary C, Ajazuddin, Alexander A, Badwaik H and Tripathi DK: Prospects of pharmaceuticals and biophar-maceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharm J. 21:125–141. 2013. View Article : Google Scholar : PubMed/NCBI
4	Chintale AG, Kadam VS, Maske KS, Raut DB, Kale SV and Rai SD: Recent advances in microsphere drug delivery system: a review. Res J Pharm Technol. 6:307–312. 2013.
5	Xia D, Yan LN, Tong Y, Wang XP, Zhang MM and Zhao LY: Construction of recombinant adenoviral vector carrying human tissue inhibitor of metalloproteinase-1 gene and its expression in vitro. Hepatobiliary Pancreat Dis Int. 4:259–264. 2005.PubMed/NCBI
6	Xia D, Yao H, Liu Q and Xu L: Preparation of microspheres encapsulating a recombinant TIMP-1 adenovirus and their inhibition of proliferation of hepatocellular carcinoma cells. Asian Pac J Cancer Prev. 13:6363–6368. 2012. View Article : Google Scholar : PubMed/NCBI
7	Singh A, Maurya OPS, Jagannadhan MV and Patel A: Matrix metalloproteinases (MMP-2 and MMP-9) activity in corneal ulcer and ocular surface disorders determined by gelatin zymography. J Ocul Biol Dis Inform. 5:31–35. 2012. View Article : Google Scholar
8	Jung JS, Ahn JH, Le TK, Kim DH and Kim HS: Protopanaxatriol ginsenoside Rh1 inhibits the expression of matrix metalloproteinases and the in vitro invasion/migration of human astroglioma cells. Neurochem Int. 63:80–86. 2013. View Article : Google Scholar : PubMed/NCBI
9	Wang ZD, Huang C, Li ZF, et al: Chrysanthemum indicum ethanolic extract inhibits invasion of hepatocellular carcinoma via regulation of MMP/TIMP balance as therapeutic target. Oncol Rep. 23:413–421. 2010.PubMed/NCBI
10	Dai ZJ, Wang BF, Lu WF, et al: Total flavonoids of Scutellaria barbata inhibit invasion of hepatocarcinoma via MMP/TIMP in vitro. Molecules. 18:934–950. 2013. View Article : Google Scholar : PubMed/NCBI
11	EI-Serg HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 142:1264–1273. 2012. View Article : Google Scholar
12	Leonardi GC, Candido S, Cervello M, et al: The tumor micro-environment in hepatocellular carcinoma. Int J Oncol. 40:1733–1747. 2012.PubMed/NCBI
13	Remacle AG, Shiryaev SA, Radichev IA, Rozanov DV, Stec B and Strongin AY: Dynamic interdomain interactions contribute to the inhibition of matrix metalloproteinases by tissue inhibitors of metalloproteinases. J Biol Chem. 286:21002–21012. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
15	Fukazawa T, Matsuoka J, Yamatsuji T, Maeda Y, Durbin ML and Naomoto Y: Adenovirus-mediated cancer gene therapy and virotherapy. Int J Mol Med. 25:3–10. 2010.
16	Liu X, Cao X, Wei R, et al: Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL. Cancer Gene Therapy. 19:49–57. 2012. View Article : Google Scholar
17	Kim KI, Park JH, Lee YJ, et al: In vivo bioluminescent imaging of α-fetoprotein-producing hepatocellular carcinoma in the diethylnitrosamine-treated mouse using recombinant adenoviral vector. J Gene Med. 14:513–520. 2012. View Article : Google Scholar : PubMed/NCBI
18	Xia D, Zhang MM and Yan LN: Recent advances in liver-directed gene transfer vectors. Hepatobiliary Pancreat Dis Int. 3:332–336. 2004.PubMed/NCBI
19	Shiba H, Okamoto T, Futagawa Y, et al: Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats. J Surg Res. 133:193–196. 2006. View Article : Google Scholar : PubMed/NCBI
20	Sailaja G, HogenEsch H, North A, Hays J and Mittal SK: Encapsulation of recombinant adenovirus into alginate micro-spheres circumvents vector-specific immune response. Gene Ther. 9:1722–1729. 2002. View Article : Google Scholar : PubMed/NCBI
21	Bertram JP, Rauch MF, Chang K and Lavik E: Using polymer chemistry to modulate the delivery of neurotrophic factors from degradable microspheres: delivery of BDNF. Pharm Res. 27:82–89. 2010. View Article : Google Scholar
22	Blatsios G, Tzimas AS, Mattheolabakis G, Panagi Z, Avgoustakis K and Gartaganis SP: Development of biodegradable controlled release scleral systems of triamcinolone acetonide. Curr Eye Res. 35:916–924. 2010. View Article : Google Scholar : PubMed/NCBI
23	Celik O and Akbuğa J: Preparation of superoxide dismutase loaded chitosan microspheres: characterization and release studies. Eur J Pharm Biopharm. 66:42–47. 2007. View Article : Google Scholar
24	Madhavan Nampoothiri K, Nair NR and John RP: An overview of the recent developments in polylactide (PLA) research. Bioresour Technol. 101:8493–8501. 2010. View Article : Google Scholar : PubMed/NCBI
25	Barakat NS and Ahmad AA: Diclofenac sodium loaded-cellulose acetate butyrate: effect of processing variables on microparticles properties, drug release kinetics and ulcerogenic activity. J Microencapsul. 25:31–45. 2008. View Article : Google Scholar : PubMed/NCBI
26	Ren Y, Zhang XJ, Chang OQ, et al: Partial characteristics of PELA-OmpK microsphere vaccine and its immune effect in crucian carp inoculated by oral route. Chinese Journal of Biologicals. 11:231–236. 2011.in Chinese.
27	Ruan G, Feng SS and Li QT: Effects of material hydrophobicity on physical properties of polymeric microspheres formed by double emulsion process. J Control Release. 84:151–160. 2002. View Article : Google Scholar : PubMed/NCBI
28	Yang YF, Tang GW, Zhang H, et al: Controlled release of BSA by microsphere-incorporated PLGA scaffolds under cyclic loading. Mater Sci and Eng, C. 31:350–356. 2011. View Article : Google Scholar
29	Wei Y, Wang YX, Wang W, Ho SV, Wei W and Ma GH: mPEG-PLA microspheres with narrow size distribution increase the controlled release effect of recombinant human growth hormone. J Mater Chem. 21:12691–12699. 2011. View Article : Google Scholar
30	Davidson BL, Hilfinger JM and Beer SJ: Extended release of adenovirus from polymer microspheres: potential use in gene therapy for brain tumors. Adv Drug Deliv Rev. 27:59–66. 1997. View Article : Google Scholar : PubMed/NCBI
31	Ahmed AR and Bodmeier R: Preparation of performed porous PLGA microparticles and antisense oligonucleotides loading. Eur J Pharm Biopharm. 71:264–270. 2009. View Article : Google Scholar
32	Mok H, Park JW and Park TG: Microencapsulation of PEGylated adenovirus within PLGA microspheres for enhanced stability and gene transfection efficiency. Pharm Res. 24:2263–2269. 2007. View Article : Google Scholar : PubMed/NCBI
33	Chaisri W, Hennink WE and Okonogi S: Preparation and characterization of cephalexin loaded PLGA microspheres. Curr Drug Deliv. 6:69–75. 2009. View Article : Google Scholar : PubMed/NCBI
34	Xu Q, Leong J, Chua QY, et al: Combined modality doxorubicin-based chemotherapy and chitosan-mediated p53 gene therapy using double-walled microspheres for treatment of human hepatocellular carcinoma. Biomaterials. 34:5149–5162. 2013. View Article : Google Scholar : PubMed/NCBI
35	Kerr SH and Kerr DJ: Novel treatments for hepatocellular cancer. Cancer Letters. 286:114–120. 2009. View Article : Google Scholar : PubMed/NCBI
36	Zhu AX: Molecularly targeted therapy for advanced hepatocellular carcinoma in 2012: current status and future perspectives. Semin Oncol. 39:493–502. 2012. View Article : Google Scholar : PubMed/NCBI